Stay updated on AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial
Sign up to get notified when there's something new on the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page.

Latest updates to the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedFooter now displays Revision: v3.4.2; the prior government funding notice (v3.4.1) has been removed.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about government funding and NIH operations and a page revision tag (v3.4.1) were added, and no study details were changed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedShow glossary feature added; two PDFs (Study Protocol and Statistical Analysis Plan) were added under Study Documents with their dates, and several metadata timestamps (Last Verified, Last Update, Results posting dates) were updated.SummaryDifference55%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 was removed.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a Locations section listing study sites (California, Illinois, Maryland) and updated the page to revision v3.3.3. The HHS Vulnerability Disclosure link was removed.SummaryDifference0.4%

- Check85 days agoChange DetectedThe page revision indicator was updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

Stay in the know with updates to AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page.